18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
Cytryn SL, Pandit-Taskar N, Lumish MA, Maron SB, Gu P, Ku GY, Chou JF, Capanu M, Antoine A, Loegel D, Feder L, Philemond S, Lyashchenko SK, Lewis JS, Paroder V, Srivastava A, Tang LH, Schoder H, Janjigian YY.
Cytryn SL, et al. Among authors: srivastava a.
J Nucl Med. 2024 May 1;65(5):722-727. doi: 10.2967/jnumed.123.267186.
J Nucl Med. 2024.
PMID: 38514081
Free PMC article.